DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam · Delayed Price · Currency is VND 95,900
0.00 (0.00%)
At close: Sep 3, 2026
DHG Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,499,324 | 13,375,323 | 13,584,517 | 13,597,591 | 11,100,341 | 14,774,306 | |
Market Cap Growth | -5.53% | -1.54% | -0.10% | 22.50% | -24.87% | 8.65% |
Enterprise Value | 10,734,498 | 11,688,546 | 11,903,276 | 11,999,699 | 8,991,684 | 12,831,532 |
Last Close Price | 95600.00 | 97280.37 | 93235.56 | 84295.06 | 66699.39 | 85981.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.40 | 16.22 | 18.03 | 13.37 | 11.60 | 19.75 |
Forward PE | 13.46 | 13.41 | 13.08 | 10.98 | 11.70 | 17.65 |
PS Ratio | 2.29 | 2.54 | 2.78 | 2.71 | 2.37 | 3.69 |
PB Ratio | 3.66 | 3.23 | 3.32 | 2.80 | 2.59 | 3.90 |
P/TBV Ratio | 3.85 | 3.38 | 3.47 | 2.91 | 2.71 | 4.12 |
P/FCF Ratio | 19.65 | 11.32 | 11.05 | - | 16.64 | 34.53 |
P/OCF Ratio | 17.52 | 11.03 | 10.31 | 56.62 | 12.32 | 32.65 |
PEG Ratio | - | 4.47 | 4.47 | 4.47 | 4.47 | 4.47 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.97 | 2.22 | 2.44 | 2.39 | 1.92 | 3.21 |
EV/EBITDA Ratio | 8.90 | 10.92 | 10.92 | 10.52 | 7.77 | 13.60 |
EV/EBIT Ratio | 9.87 | 12.27 | 12.93 | 11.40 | 8.36 | 14.91 |
EV/FCF Ratio | 16.87 | 9.89 | 9.69 | - | 13.48 | 29.99 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | 0.16 | 0.12 | 0.03 | 0.06 |
Debt / EBITDA Ratio | - | - | 0.60 | 0.50 | 0.10 | 0.22 |
Debt / FCF Ratio | - | - | 0.53 | - | 0.17 | 0.49 |
Net Debt / Equity Ratio | -0.52 | -0.52 | -0.53 | -0.30 | -0.51 | -0.48 |
Net Debt / EBITDA Ratio | -1.46 | -2.01 | -1.98 | -1.30 | -1.89 | -1.92 |
Net Debt / FCF Ratio | -2.77 | -1.82 | -1.76 | 6.02 | -3.27 | -4.23 |
Asset Turnover | 1.04 | 0.95 | 0.81 | 0.89 | 0.96 | 0.88 |
Inventory Turnover | 2.40 | 2.58 | 2.07 | 1.92 | 2.08 | 2.19 |
Quick Ratio | 1.59 | 2.92 | 1.91 | 2.25 | 3.28 | 3.18 |
Current Ratio | 2.47 | 4.03 | 2.57 | 3.90 | 5.20 | 4.92 |
Return on Equity (ROE) | 26.74% | 20.71% | 17.41% | 22.98% | 24.45% | 21.09% |
Return on Assets (ROA) | 12.95% | 10.70% | 9.53% | 11.66% | 13.74% | 11.87% |
Return on Invested Capital (ROIC) | 48.04% | 41.99% | 29.86% | 34.82% | 47.31% | 41.63% |
Return on Capital Employed (ROCE) | 31.20% | 22.60% | 22.10% | 21.40% | 24.70% | 22.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.46% | 6.37% | 5.73% | 7.73% | 8.91% | 5.26% |
FCF Yield | 5.09% | 8.84% | 9.05% | -1.81% | 6.01% | 2.90% |
Dividend Yield | 5.23% | 5.14% | 10.73% | 8.90% | 5.25% | 4.07% |
Payout Ratio | 140.19% | 153.39% | 125.89% | 43.55% | 46.30% | 67.29% |
Total Shareholder Return | 6.11% | 5.14% | 10.73% | 8.90% | 5.25% | 4.07% |